Core Viewpoint - *ST Jiyao (300108) has been decided to be delisted by the Shenzhen Stock Exchange due to triggering mandatory delisting conditions, with the delisting date set for May 29, 2025 [1][2]. Summary by Sections Company Announcement - On May 28, 2025, *ST Jiyao announced that its stock would be terminated from listing by the Shenzhen Stock Exchange, effective May 29, 2025, without entering a delisting adjustment period [1]. - The company received the termination notice on May 26, 2025, and is required to ensure its shares can enter the National Equities Exchange and Quotations (NEEQ) within 45 trading days after delisting [1]. Shareholder Information - As of March 31, 2025, *ST Jiyao had 28,056 shareholders [2]. Stock Trading Activity - Prior to its suspension on April 24, 2025, *ST Jiyao's stock price was reported at 0.21 CNY per share. On the last trading day before suspension, the stock opened at a limit-down price of 0.19 CNY, briefly rising to 0.23 CNY with a turnover rate of 29.42%, and a total trading volume of nearly 40 million CNY [4]. - The stock experienced significant price fluctuations, with a cumulative price drop deviation of 30% over two consecutive trading days and 50% over four trading days, indicating severe abnormal trading conditions [4]. Company Background - *ST Jiyao, established in 2000, operates in the pharmaceutical industry, including manufacturing, wholesale, retail, and healthcare services. The company transitioned from a chemical focus to pharmaceuticals through acquisitions starting in 2014 [6]. - The company has faced continuous losses since 2019, with a reported revenue of 333.33 million CNY in 2024, a decrease of 3.69% year-on-year, and a net loss of 439.43 million CNY, worsening from a loss of 349.31 million CNY in the previous year [6][7]. Financial Performance - As of the end of 2024, *ST Jiyao's total assets were approximately 1.44 billion CNY, down 24.52% from the previous year, and the net assets attributable to shareholders were negative 776.52 million CNY, a decline of 176.66% [7]. - In the first quarter of 2025, the company reported a revenue of 63.74 million CNY, a year-on-year decrease of 15.53%, and a net loss of 45.17 million CNY, compared to a loss of 40.85 million CNY in the same period last year [8].

Group 1 - Jia Ying Pharmaceutical is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, having received a notice of case filing on May 28, 2025 [2] - ST United plans to acquire 100% of Run Tian Industrial through a combination of share issuance and cash payment, aiming to enhance its positioning as a comprehensive service provider in cultural tourism consumption [3] - Long Gao Co., Ltd. announced the restructuring of its controlling shareholder, Longyan Investment Development Group, which has established a new investment development group with a registered capital of 3 billion yuan [4] Group 2 - Sanyou Chemical's controlling shareholder intends to inject 100 million yuan into its subsidiary, Tangshan Sanyou Silicon Industry Co., Ltd., through a private agreement, without affecting the consolidation scope of the company [5] - ST Ji Pharmaceutical's stock will be delisted on May 29, 2025, due to a continuous closing price below 1 yuan for twenty trading days, triggering termination of listing rules [6] - Taiji Industrial plans to repurchase shares worth 100 million to 120 million yuan, with a maximum repurchase price of 10.38 yuan per share [7] Group 3 - China Energy Construction's subsidiary has won a bid for a coal power project worth approximately 14.586 billion yuan, marking a significant contract win [8][9]

证券代码：300108 证券简称：*ST 吉药 公告编号：2025-085 吉药控股集团股份有限公司 关于公司股票终止上市暨摘牌的公告 本公司及其董事会全体成员保证公告内容真实、准确、完整，公告不存 在虚假记载、误导性陈述或重大遗漏。 特别提示： 吉药控股集团股份有限公司（以下简称"公司"）股票已被深圳证券交易所 决定终止上市，将在 2025 年 5 月 29 日被摘牌。 公司于 2025 年 5 月 26 日收到深圳证券交易所《关于吉药控股集团股份有 限公司股票终止上市的决定》（深证上〔2025〕第 517 号），鉴于公司股票被 深圳证券交易所决定终止上市，根据《深圳证券交易所创业板股票上市规则 （2024 年修订）》《关于退市公司进入退市板块挂牌转让的实施办法》等的相 关规定，公司应当在股票被终止上市后及时做好相关工作，以确保公司股份在 摘牌后四十五个交易日内可以进入全国中小企业股份转让系统有限责任公司依 托原证券公司代办股份转让系统设立并代为管理的两网公司及退市公司板块 （以下简称"退市板块"）挂牌转让。 二、终止上市决定的主要内容 吉药控股集团股份有限公司： 你公司股票在 2025 年 3 月 26 ...

Core Viewpoint - *ST Jiyuan (300108.SZ) has announced that its stock will be delisted from the Shenzhen Stock Exchange, effective May 29, 2025, due to a continuous closing price below 1 yuan for twenty trading days from March 26 to April 23, 2025, which violates the listing rules of the ChiNext board [1] Summary by Category Company Announcement - The company has engaged Shanxi Securities Co., Ltd. as its lead underwriter and has signed a "Stock Transfer Entrustment Agreement" with them [1]

吉药控股集团股份有限公司 第六届董事会第八次会议决议的公告 本公司及其董事会全体成员保证公告内容真实、准确、完整，公告不 存在虚假记载、误导性陈述或重大遗漏。 一、 董事会会议召开情况 1、吉药控股集团股份有限公司（以下简称"公司"）第六届董事会第八次 会议（以下简称"本次会议"）通知于2025年5月16日以邮件、电话等形式发出。 2、本次会议于2025年5月27日以现场结合通讯表决方式在公司会议室召开。 3、本次会议应出席董事5名，实际出席董事5名。 4、本次会议由董事长刘晓峰先生召集和主持。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等有 关法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 证券代码：300108 证券简称：*ST 吉药 公告编号：2025-084 经与会董事表决，形成决议如下： （一）审议通过《关于聘请主办券商的议案》 公司于 2025 年 5 月 26 日收到深圳证券交易所《关于吉药控股集团股份有 限公司股票终止上市的决定》（深证上〔2025〕第 517 号），深圳证券交易所 决定终止公司股票上市。根据深交所《深圳证券交易所创业板股票上市规 则》、《关 ...

证券代码：300108 证券简称：*ST 吉药 公告编号：2025-083 吉药控股集团股份有限公司 关于聘请主办券商的公告 本公司及其董事会全体成员保证公告内容真实、准确、完整，公告不存 在虚假记载、误导性陈述或重大遗漏。 一、聘请主办券商的情况说明 吉药控股集团股份有限公司（以下简称"公司"）于 2025 年 5 月 26 日收到 深圳证券交易所《关于吉药控股集团股份有限公司股票终止上市的决定》（深证 上〔2025〕第 517 号），深圳证券交易所决定终止公司股票上市。具体内容详见 公司同日在巨潮资讯网披露的《关于收到股票终止上市决定的公告》（公告编号： 2025-082）。 根据《深圳证券交易所创业板股票上市规则（2024 年修订）》《关于退市 公司进入退市板块挂牌转让的实施办法》等相关规定，公司股票终止上市后，将 转入全国股转公司代为管理的退市板块。公司应当聘请符合规定条件的证券公司 （以下简称"主办券商"），办理公司股票在交易所摘牌后进入退市板块挂牌转让 的相关业务，并授权其办理交易所市场的股份退出登记、股份重新确认、退市板 块的股份初始登记、股票挂牌及提供股份转让服务等。 2025 年 5 月 2 ...

证券代码：300108 证券简称：*ST 吉药 公告编号：2025-081 吉药控股集团股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚 假记载、误导性陈述或重大遗漏。 特别提示： 本次股东大会无否决、修改、增加提案的情况。 一、会议召开和出席情况 1、召集人：公司董事会 2、召开方式：现场投票与网络投票相结合的方式 3、召开时间： 现场会议时间为：2025 年 5 月 21 日 14:00 网络投票时间为：2025 年 5 月 21 日 其中，通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 5 月 21 日 上午 9:15-9:25、9:30-11:30，下午 1:00-15:00；通过深圳证券交易所互联网系统投票 的具体时间为 2025 年 5 月 21 日 上午 9:15 至下午 3:00 期间的任意时间。 4、股权登记日：2025 年 5 月 14 日（星期三） 5、现场会议召开地点：梅河口市环城北路 6 号吉药控股集团股份有限公司 会议室 6、现场会议主持人：董事长刘晓峰先生 7、出席会议情况： 出席公司本次股东大会的股 ...

京天股字（2025）第 335 号 致：吉药控股集团股份有限公司 吉药控股集团股份有限公司（以下简称"公司"）2024 年年度股东大会（以下简 称"本次股东大会"）采取现场投票与网络投票相结合的方式召开，其中现场会议于 2025 年 5 月 21 日在梅河口市环城北路 6 号吉药控股集团股份有限公司会议室召 开。北京市天元律师事务所（以下简称"本所"）接受公司聘任，指派本所律师参加 本次股东大会会议，并根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 （以下简称"《股东会规则》"）以及《吉药控股集团股份有限公司章程》（以下简 称"《公司章程》"）等有关规定，就本次股东大会的召集、召开程序、出席现场会 议人员的资格、召集人资格、会议表决程序及表决结果等事项出具本法律意见。 或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充 分的核查验证，保证本法律意见所认定的事实真实、准确、完整，所发表的结论性意 见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并承担相应法律责任。 为出具本法律意见，本所律师审查了 ...

Summary of Key Points Core Insights - The report highlights the upcoming listings and trading activities of several companies on May 19, 2025, indicating a busy market day with multiple new entries [1][2][3]. Upcoming Listings - Company 001390 Guqi Fur Material will be available for online subscription on May 19, 2025 [1]. - Companies 301595 N Taili and 603014 N Weigao will officially list on the same day, with allocations for general institutional investors [1]. - Company 920060 Wanyuantong will also list on May 19, 2025, specifically for the public portion [1]. Suspension Announcements - Company 002092 ST Zhongtai and 002259 ST Shengda will be suspended for one day due to the announcement of the withdrawal of other risk warnings [2]. - The Invesco Great Wall S&P Consumer Select ETF (QDII) and Guotai S&P 500 ETF will also be suspended until 10:30 AM on May 19, 2025, to protect investor interests [2]. - Company 300506 *ST Mingjia will be suspended for one day following the announcement of the withdrawal of delisting risk warnings [2]. Special Suspensions - Company 000151 Zhongcheng Co. will be suspended due to plans for issuing shares to acquire assets and raise matching funds, effective from May 16, 2025 [3]. - Company 000584 *ST Gongzhi and 000622 *ST Hengli will also face suspensions due to potential delisting risks and failure to disclose periodic reports within the legal timeframe [3]. - Company 002336 *ST Renle will be suspended for one day due to the announcement of potential delisting risks [3].

Group 1 - The average stock price of A-shares is 11.51 yuan, with 60 stocks priced below 2 yuan, the lowest being *ST Jiyao at 0.21 yuan [1] - Among the low-priced stocks, 24 are ST stocks, accounting for 40% of the total [1] - The Shanghai Composite Index closed at 3367.46 points on May 16 [1] Group 2 - Among the low-priced stocks, 10 stocks increased in price, with *ST Jinguang, Puli Tui, and *ST Jinke leading with increases of 4.76%, 2.27%, and 1.97% respectively [1] - 33 stocks decreased in price, with ST Lingnan, *ST Xingguang, and *ST Baoying showing the largest declines of 5.23%, 4.88%, and 3.14% respectively [1] - The stock price distribution indicates that both high-priced and low-priced stocks constitute a relatively small proportion of the A-share market [1]